Exploring the targets and molecular mechanism of glycyrrhetinic acid against diabetic nephropathy based on network pharmacology and molecular docking

Figure 3 Targets and protein-protein interaction network enrichment analysis. A: Drug targets and disease genes; B: Intersection of drug and disease targets; C: Protein-protein interaction (PPI) network diagram of intersection genes between glycyrrhetinic acid (GA) and the disease; D: Utilization of Cytoscape to construct a PPI network comprising 186 common targets and 2 core targets for potential disease treatment; E: Analysis results of selected core targets and GA’s active components. Each node’s color denotes its degree.